SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. ($DJT) is experiencing significant trading activity following its announced merger with fusion energy firm TAE Technologies in a deal valued at over $6 billion. This strategic pivot into the highly speculative fusion energy sector, with aspirations to power the AI boom, has ignited polarized community discussions, with supporters bullish on its long-term potential as an early publicly traded fusion play, while critics remain skeptical, viewing it as a speculative event.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending after its recent earnings report, which, despite beating estimates, revealed weak forward guidance and a significant sales decline in China. This has sparked a heated debate among investors, with some viewing the sharp stock drop as an overreaction and a long-term buying opportunity, while others express concerns over product quality, increasing competition from newer brands, and the ongoing impact of tariffs.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is experiencing extreme volatility and a sharp sell-off, primarily driven by widespread forecasts for unseasonably warm weather which are dampening immediate natural gas demand. The community is fiercely divided, with some anticipating a strong rebound from oversold conditions, while others emphasize the inherent decay of this leveraged ETF and the persistence of mild winter outlooks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending due to heightened community discussion around its AI, robotics, and autonomous driving initiatives, fueled by recent sightings of Cybercab testing. While bulls anticipate significant future growth from these ventures, many skeptics question the stock's valuation given its current automotive sales and fundamental performance.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber (WYFI) is trending following news of a significant 10-year, 40 MW colocation agreement with Nscale for its NC-1 data center campus, representing approximately $865 million in contract value for AI infrastructure. The community is buzzing with excitement over this substantial deal, anticipating strong price momentum and a potential short squeeze given the stock's low float. Investors are keenly discussing the company's enhanced position within the booming AI data center sector, citing recent analyst upgrades and the long-term implications of this contract.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending amid discussions surrounding a new Joint Development Agreement with an unnamed top-tier global automaker and its impending move to the Nasdaq exchange. The community is keenly focused on whether these catalysts, alongside progress on its Eagle Line facility, mark a turning point towards scalable commercialization for its solid-state battery technology. While many express strong conviction for future growth, others remain vigilant about the pace of production and full public disclosure from partners.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is a hot topic, with recent analyst upgrades and its CEO's discussion of strategic partnerships, like OpenTable, driving conversation around its voice AI potential. Bullish investors are advocating for accumulation, viewing current prices as a deep value opportunity in the burgeoning agentic AI space. Conversely, a significant portion of the community expresses frustration over the stock's persistent price weakness and lack of sustained upward momentum, fueling a contentious debate on its near-term prospects.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX Token is trending as the community eagerly anticipates an imminent breakout from a prolonged downtrend, with many actively accumulating at current levels. Enthusiasts highlight FOX's exceptionally low market cap and strong fundamentals compared to major decentralized exchange competitors, fueling expectations of a substantial rally and "super cycle" as broader market conditions improve. The token's potential for significant upside is a key talking point among holders who believe it's currently undervalued.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Vanguard Group, Inc. - Vanguard Information Technology ETF

Vanguard Information Technology ETF

Vanguard Information Technology ETF ($VGT) is trending as robust performance from its major holdings, including Apple, Microsoft, and NVIDIA, continues to fuel optimism for the broader technology sector and the ongoing AI revolution. The community widely views VGT as a strong long-term growth vehicle, actively debating whether to buy recent dips or accumulate further given its sustained performance and favorable expense ratio compared to peers. Despite broader market uncertainties, investors remain keen on VGT's comprehensive exposure to leading tech innovators.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026?

Mirum's Livmarli sales surge 70% in the first nine months of 2025. Expanding approvals and commercialization are set to fuel revenue momentum into 2026.

Stifel Nicolaus Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price

Stifel Nicolaus upped their target price on shares of Mirum Pharmaceuticals from $92.00 to $98.00 and gave the company a "buy" rating in a research report on Tuesday...

Eventide Asset Management LLC Has $134.22 Million Holdings in Mirum Pharmaceuticals, Inc. $MIRM

Eventide Asset Management LLC raised its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 4.4% during the second quarter, according to its most recent filing with the Securities...

Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by BVF Inc. IL

BVF Inc. IL lessened its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 1.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional...

Boone Capital Management LLC Has $32.64 Million Stock Position in Mirum Pharmaceuticals, Inc. $MIRM

Boone Capital Management LLC grew its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 6.3% during the second quarter, according to its most recent filing with the...

What is HC Wainwright's Forecast for MIRM FY2025 Earnings?

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - HC Wainwright increased their FY2025 earnings estimates for shares of Mirum Pharmaceuticals in a note issued to investors on Tuesday...

<ul class="summary-bullets"><li>Brelovitug is a late-stage experimental drug being studied for chronic hepatitis delta virus infection.&nbsp;</li><li>The transaction with Bluejay is expected to close in the first quarter of 2026.</li><li>Mirum said it had secured $200 million through a private placement to be used to fund clinical development and commercial activities following the proposed acquisition.</li></ul><p>Shares of Mirum Pharmaceuticals, Inc. (MIRM) fell as much as 5% on Monday morning after the company announced that it has agreed to buy privately held Bluejay Therapeutics in a deal worth up to $820 million.</p><p>The move is aimed at advancing the company in rare disease by adding Bluejay’s Brelovitug to its portfolio. Brelovitug is a late-stage experimental drug being studied for chronic hepatitis delta virus (HDV) infection, a most severe form of viral hepatitis in which nearly half of those affected progress to liver-related death within 10 years of diagnosis.</p><h2 class="st-heading-2">Deal Terms</h2><p>Under the deal, Mirum has <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251208788160/en/Mirum-Pharmaceuticals-Enters-into-Definitive-Agreement-to-Acquire-Bluejay-Therapeutics-Expanding-Global-Leadership-in-Rare-Disease">agreed</a> to acquire all outstanding shares of Bluejay for $250 million in cash and $370 million in Mirum common stock, in addition to potential sales-based milestone payments of up to $200 million in cash.</p><p>The transaction with Bluejay is expected to close in the first quarter of 2026, subject to regulatory approval and other customary closing conditions, the company added.</p><h2 class="st-heading-2">About the Liver Drug&nbsp;</h2><p>Brelovitug is currently in late stage trials for HDV. In mid-stage trials, Brelovitug demonstrated strong antiviral activity in HDV and improvements in liver enzyme levels and a favorable safety profile.</p><p>Mirum said on Monday that it expects top-line data from the late-stage trial in the second half of 2026, with application to the FDA for potential approval slated for 2027.</p><p>Mirum also said that it will evaluate strategic options for Bluejay’s additional investigational programs after closing of the deal.</p><h2 class="st-heading-2">Placement Announcement</h2><p>Mirum on Monday also said that it has entered into a definitive agreement with a syndicate of existing and new healthcare investors, for the sale of Mirum common stock and pre-funded warrants, in a private placement.</p><p>The private placement is expected to result in gross proceeds of $200 million which will be used to fund clinical development and commercial activities following the proposed acquisition, the company said.</p><h2 class="st-heading-2">Expert Take</h2><p>Cantor Fitzgerald subsequently raised the price target on Mirum to $130 from $95, while keeping an ‘Overweight’ rating on the shares. The new price target represents a potential upside of about 90% from the stock’s closing price on Friday.</p><p>Cantor opined that Mirum’s proposed acquisition of Bluejay under the agreed-upon terms is a “steal.”</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MIRM">MIRM</a> jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.</p><figure class="image"><img style="aspect-ratio:586/57;" src="data:image/png;base64,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" alt="MIRM’s Sentiment Meter and Message Volume as of 11:13 a.m. ET on Dec. 08, 2025 | Source: Stocktwits" width="586" height="57"><figcaption>MIRM’s Sentiment Meter and Message Volume as of 11:13 a.m. ET on Dec. 08, 2025 | Source: Stocktwits</figcaption></figure><p>MIRM stock has gained 64% this year and by about 57% over the past 12 months.</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/apple-chip-chief-reportedly-dismisses-concerns-about-exit/cLIYHDjREmk">Apple Chip Chief Reportedly Dismisses Concerns About Exit: ‘I Love My Job’</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

Esperion’s stock (ESPR) has risen 40.5% so far in 2025. (Representative Image: Getty Images)

Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal'

The move is aimed at advancing the company in rare disease by adding Bluejay’s Brelovitug to its portfolio.

Equity

The move is aimed at advancing the company in rare disease by adding Bluejay’s Brelovitug to its portfolio.


Mirum Pharmaceuticals To Acquire Bluejay Therapeutics In Rare Liver Disease Expansion

(RTTNews) - Mirum Pharmaceuticals (MIRM) on Monday announced that it has agreed to acquire Bluejay Therapeutics in a deal valued at $620 million in cash and stock, adding brelovitug, a late-stage...

Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced its entry into a definitive agreement to acquire Bluejay Therapeutics, a privately held biotechnology...

Mirum Pharmaceuticals (MIRM) Up 1.3% Since Last Earnings Report: Can It Continue?

Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Mirum Pharmaceuticals Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

MIRM
Mirum Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MIRM News

MIRMMirum Pharmaceuticals Inc